Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,710 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Active, Not Recruiting

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT07220577

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Ctr for Dermatology Clinical Res Fremont, California, United States
  • Aesthetics Skin Care Dermatologic Surgery Rockville, Maryland, United States
  • Care Access Hoboken Hoboken, New Jersey, United States
  • Novartis Investigative Site Pleven, Bulgaria
View all 28 locations
View Trial Details
Active, Not Recruiting

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

NCT06966479

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Kern Research, Inc. Bakersfield, California, United States
  • California Medical Research Associates Inc. Northridge, California, United States
  • Integrated Research of Inland Inc Upland, California, United States
  • Allergy & Asthma Clinical Research Walnut Creek, California, United States
View all 102 locations
View Trial Details
Active, Not Recruiting

Using Commonly Available Food Products To Treat Food Allergy

NCT05503446

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +5 more
Locations
  • University of Hospitals of Leicester NHS Trust Leicester, United Kingdom
  • Imperial College Healthcare NHS Trust London, United Kingdom
  • Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle, United Kingdom
  • Sheffield Children's Hospital NHS Foundation Trust Sheffield, United Kingdom
View Trial Details
Active, Not Recruiting

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

NCT06863961

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • First OC Dermatology Fountain Valley, California, United States
  • The Center for Dermatology Clinical Research Fremont, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Dermatology Research Associate Los Angeles, California, United States
View all 68 locations
View Trial Details

Related conditions